Cargando…

Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood

Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Crespo-Lessmann, Astrid, Mateus, Eder, Torrejón, Montserrat, Belda, Alicia, Giner, Jordi, Vidal, Silvia, Sibila, Oriol, Plaza, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644553/
https://www.ncbi.nlm.nih.gov/pubmed/29066918
http://dx.doi.org/10.2147/JAA.S142200
_version_ 1783271746404614144
author Crespo-Lessmann, Astrid
Mateus, Eder
Torrejón, Montserrat
Belda, Alicia
Giner, Jordi
Vidal, Silvia
Sibila, Oriol
Plaza, Vicente
author_facet Crespo-Lessmann, Astrid
Mateus, Eder
Torrejón, Montserrat
Belda, Alicia
Giner, Jordi
Vidal, Silvia
Sibila, Oriol
Plaza, Vicente
author_sort Crespo-Lessmann, Astrid
collection PubMed
description Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory phenotype of asthma with bronchial hypersecretion of mucus. 2) Compare the type of mucin present in induced sputum (IS) of patients with and without bronchial hypersecretion. 3) Determine the expression of TLRs in IS and blood of asthmatics with and without bronchial hypersecretion. MATERIALS AND METHODS: Cross-sectional study which included 43 non-smoking asthmatic patients without bronchiectasis, 19 with bronchiectasis, and 24 without bronchial hypersecretion. All patients underwent the following: IS, spirometry, fractional exhaled nitric oxide, prick test, total immunoglobulin E (IgE), and blood albumin. Analysis of mucins was determined by ELISA and expression of TLR2 and TLR4 by flow cytometry. The level of asthma control was determined by the Asthma Control Test (ACT) questionnaire and quality of life was assessed by the reduced version of the Asthma Quality of Life Questionnaire (mini-AQLQ). RESULTS: Asthmatics with bronchial hypersecretion were significantly older (62.6 years vs 48.5 years; p=0.02); had greater severity (persistent severe asthma 94.7% vs 29.2%; p=0.000); a higher proportion of nasal polyposis (36.8% vs 8.3%; p=0.022); less control of asthma (73.7% vs 8.3%; p=0,000); a higher proportion of asthma with negative prick test (68.4% vs 16.6%; p=0.001), and lower levels of IgE (113.4 IU/mL vs 448 IU/mL; p=0.007), compared with asthmatics without bronchial hypersecretion. Significant differences were observed neither in the expression of TLRs 2 and 4 in inflammatory cells of IS or peripheral blood, nor in the expression of mucins between both groups. CONCLUSION: Asthma patients with bronchial hypersecretion have more severe and uncontrolled disease, with poor quality of life as well as a non-allergic inflammatory phenotype. Within the mechanisms involving these differences, it does not appear that mucins and TLRs play an important role.
format Online
Article
Text
id pubmed-5644553
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56445532017-10-24 Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood Crespo-Lessmann, Astrid Mateus, Eder Torrejón, Montserrat Belda, Alicia Giner, Jordi Vidal, Silvia Sibila, Oriol Plaza, Vicente J Asthma Allergy Original Research Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC). OBJECTIVES: 1) Define the clinical and inflammatory phenotype of asthma with bronchial hypersecretion of mucus. 2) Compare the type of mucin present in induced sputum (IS) of patients with and without bronchial hypersecretion. 3) Determine the expression of TLRs in IS and blood of asthmatics with and without bronchial hypersecretion. MATERIALS AND METHODS: Cross-sectional study which included 43 non-smoking asthmatic patients without bronchiectasis, 19 with bronchiectasis, and 24 without bronchial hypersecretion. All patients underwent the following: IS, spirometry, fractional exhaled nitric oxide, prick test, total immunoglobulin E (IgE), and blood albumin. Analysis of mucins was determined by ELISA and expression of TLR2 and TLR4 by flow cytometry. The level of asthma control was determined by the Asthma Control Test (ACT) questionnaire and quality of life was assessed by the reduced version of the Asthma Quality of Life Questionnaire (mini-AQLQ). RESULTS: Asthmatics with bronchial hypersecretion were significantly older (62.6 years vs 48.5 years; p=0.02); had greater severity (persistent severe asthma 94.7% vs 29.2%; p=0.000); a higher proportion of nasal polyposis (36.8% vs 8.3%; p=0.022); less control of asthma (73.7% vs 8.3%; p=0,000); a higher proportion of asthma with negative prick test (68.4% vs 16.6%; p=0.001), and lower levels of IgE (113.4 IU/mL vs 448 IU/mL; p=0.007), compared with asthmatics without bronchial hypersecretion. Significant differences were observed neither in the expression of TLRs 2 and 4 in inflammatory cells of IS or peripheral blood, nor in the expression of mucins between both groups. CONCLUSION: Asthma patients with bronchial hypersecretion have more severe and uncontrolled disease, with poor quality of life as well as a non-allergic inflammatory phenotype. Within the mechanisms involving these differences, it does not appear that mucins and TLRs play an important role. Dove Medical Press 2017-10-12 /pmc/articles/PMC5644553/ /pubmed/29066918 http://dx.doi.org/10.2147/JAA.S142200 Text en © 2017 Crespo-Lessmann et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Crespo-Lessmann, Astrid
Mateus, Eder
Torrejón, Montserrat
Belda, Alicia
Giner, Jordi
Vidal, Silvia
Sibila, Oriol
Plaza, Vicente
Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title_full Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title_fullStr Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title_full_unstemmed Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title_short Asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
title_sort asthma with bronchial hypersecretion: expression of mucins and toll-like receptors in sputum and blood
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644553/
https://www.ncbi.nlm.nih.gov/pubmed/29066918
http://dx.doi.org/10.2147/JAA.S142200
work_keys_str_mv AT crespolessmannastrid asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT mateuseder asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT torrejonmontserrat asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT beldaalicia asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT ginerjordi asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT vidalsilvia asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT sibilaoriol asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood
AT plazavicente asthmawithbronchialhypersecretionexpressionofmucinsandtolllikereceptorsinsputumandblood